Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Global First-in-Class AT2R Antagonist TRD205 Advances to Phase II: First Patient Dosed in Chronic Post-Surgical Neuropathic Pain Trial 2025-05-06 07:00
Penpulimab Monoclonal Antibody (PD-1) Obtains Marketing Approval in China 2021-08-06 09:39
1